ProMetic offers its state of the art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders.

ProMetic uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop best-in-class therapeutics and orphan drugs.

ProMetic is also active in developing its own novel small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, cancer and autoimmune diseases/inflammation.

 

GENERIUM - PROMETIC, STRATEGIC ALLIANCE WEBCAST

click here to listen

GENERIUM - PROMETIC, STRATEGIC ALLIANCE PRESENTATION

Click here to view the presentation

 

 

ProMetic BioProduction Corporate Video

Click here to view the video

 

Learn More »